Researchers have shown that a new drug, Alirocumab, can cut back the "bad" cholesterol to the level of a baby.
According to the Daily Express, Alirocumab is being hailed as the latest weapon against heart attacks and stroke, after a study of more than 2,000 patients found that it eliminated dangerous blood fats in more than a third of people taking statins.
Cholesterol-Lowering Statins Must be Taken by the Elderly
Cholesterol-lowering drugs called statins can be taken by nearly everyone aged 66 to 75, to reduce their risk of heart attack and stroke, new guidelines say.
Advertisement
Lead researcher Professor Kausik Ray said that around 40 percent of people who took it saw their levels reduce to that of a newborn, and the medication is being referred to as the Pac-Man drug because, as it "gobbles up" a protein and allows the body to get free of bad cholesterol.
Amongst the 2,338 patients who took part in the trial, 788 were given a placebo and 1,550 Alirocumab and a statin, where of the 1,550, 562 saw their level of bad cholesterol fall to less than a baby's level within a year.
![Warding Off High Cholesterol by Avoiding 'Midnight Snacking']( "Warding Off High Cholesterol by Avoiding 'Midnight Snacking'")
Confining caloric consumption to an 8- to 12-hour period and avoiding midnight snacking can stave off high cholesterol, diabetes and obesity, reveals a new study.
Statins can reduce LDL cholesterol by up to 50 percent and this drug reduced it by a further 50 per cent.
Prof. Ray said that it was the biggest reduction they had since statins were introduced, and though it was likely to reduce the risk of heart disease, the risk wouldn't be eliminated.
Source: ANI
Warding Off High Cholesterol by Avoiding 'Midnight Snacking'
Confining caloric consumption to an 8- to 12-hour period and avoiding midnight snacking can stave off high cholesterol, diabetes and obesity, reveals a new study.
Advertisement
Statins can reduce LDL cholesterol by up to 50 percent and this drug reduced it by a further 50 per cent.
Prof. Ray said that it was the biggest reduction they had since statins were introduced, and though it was likely to reduce the risk of heart disease, the risk wouldn't be eliminated.
Source: ANI
Automated Reminders Improve Cholesterol Control: Study
People who received automated reminders were more likely to refill their blood pressure and cholesterol medications, claims a study published in a special issue of the American Journal of Managed Care .
Advertisement
 Two New Genetic Variants Influencing Cholesterol Levels During Statin Therapy IdentifiedA new study that involved 40,000 people identified two new genetic variants which influence how 'bad' cholesterol levels respond to statin therapy. | Advertisement
|
Advertisement
Recommended Readings
Latest Research News
Scientists identified mechanisms governing immune cells, selectively removing troublemakers to reshape skin immunity. Benefits those with psoriasis, vitiligo.
By 2050, an anticipated increase from 494 million cases in 2020 to 1.06 billion people with musculoskeletal disabilities is expected.
Experts consulted by GlobalData anticipate a significant overhaul in the Gaucher disease scenario because of forthcoming gene therapies in development.
Within the seven major markets, 12% to 20% of diagnosed prevalent NASH cases present severe liver damage (stage 4 liver fibrosis), denoting cirrhosis.
Memory deficits in individuals with epilepsy, especially cognitive difficulties, might partially stem from the transient impairments caused by these slow waves.